EQT sells 6.3% of Galderma's share capital via accelerated bookbuilding process

Sunshine SwissCo GmbH (a consortium led by EQT), the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. have announced the launch of an accelerated bookbuilding process for the successful placement of 15,000,000 shares in Galderma Group AG.

The per-share price was CHF 89, raising a total of around CHF 1.335 billon. The sale was offered to professional investors in Switzerland and to qualified investors outside Switzerland.

The sellers will remain shareholders of 48.18% of the share capital of Galderma.

EQT’s representation on the board of directors of Galderma remains unchanged as a result of the placement, while the placement will broaden Galderma’s shareholder base and free float.

The sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma. The placement settled on March 13, 2025, and no changes to the Galderma board of directors and its governance are envisioned.

Law firm Homburger acted as transaction counsel to EQT, with a team led by Frank Gerhard (corporate/ M&A, capital markets) and included Margrit Marti, Estelle Piccard, Héloïse de Jamblinne and Lucas Forrer (all corporate / M&A, capital markets), Micha Fankhauser (financial market regulation) as well as Stefan Oesterhelt (tax).